SON Stock Analysis: Sonoco Products | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 4.795m USD | 12M Return: 23.7% | US8354951027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.7M
EPS Trend: 56.2%
Qual. Beats: 0
Rev. Trend: 25.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sonoco Products Company (NYSE: SON) is a global packaging manufacturer operating two main business segments: Consumer Packaging, which produces rigid paper, steel, and plastic containers along with closures and metal ends, and Industrial Paper Packaging, which supplies paperboard tubes, cones, cores, protective packaging, and uncoated recycled paperboards. The company also distributes a broader range of packaging materials, including plastic, paper, foam, and specialty products, serving end markets such as paper, textile, film, food, construction, and wire and cable. Headquartered in Hartsville, South Carolina, Sonoco was founded in 1899 and is classified as a mid-cap stock within the GICS Materials sector, specifically the Paper & Plastic Packaging Products & Materials sub-industry.
As a diversified packaging producer with a presence in both consumer and industrial channels, Sonocos business model spans commodity-adjacent inputs (paperboard, recycled fiber) and value-added converted products, giving it exposure to multiple downstream industries. The inclusion of uncoated recycled paperboards in its portfolio reflects the broader packaging sectors emphasis on recycled content and circular-economy sourcing as buyers and regulators increasingly prioritize sustainable materials.
- Eviosys acquisition expands metal food packaging revenue and global footprint
- Industrial Paper Packaging segment review explores divestiture to streamline portfolio
- Sustainable packaging demand grows amid global plastic regulation and ESG mandates
| Net Income: 646.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.48 > 1.0 |
| NWC/Revenue: -0.19% < 20% (prev 10.83%; Δ -11.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 637.1m > Net Income 646.8m |
| Net Debt (4.80b) to EBITDA (1.55b): 3.10 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.7m) vs 12m ago 0.30% < -2% |
| Gross Margin: 20.81% > 18% (prev 21.26%; Δ -0.45% > 0.5%) |
| Asset Turnover: 65.04% > 50% (prev 47.32%; Δ 17.72% > 0%) |
| Interest Coverage Ratio: 5.07 > 6 (EBIT TTM 1.03b / Interest Expense TTM 203.1m) |
| A: -0.00 (Total Current Assets 2.79b - Total Current Liabilities 2.80b) / Total Assets 11.0b |
| B: 0.31 (Retained Earnings 3.44b / Total Assets 11.0b) |
| C: 0.09 (EBIT TTM 1.03b / Avg Total Assets 11.5b) |
| D: 0.49 (Book Value of Equity 3.60b / Total Liabilities 7.38b) |
| Altman-Z'' = 2.13 = BBB |
| DSRI: 0.72 (Receivables 1.20b/1.27b, Revenue 7.46b/5.66b) |
| GMI: 1.02 (GM 21.26% / 20.81%) |
| AQI: 0.98 (AQ_t 0.47 / AQ_t-1 0.48) |
| SGI: 1.32 (Revenue 7.46b / 5.66b) |
| TATA: 0.00 (NI 646.8m - CFO 637.1m) / TA 11.0b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of October 12, 2026, the stock is trading at USD 47.92 with a total of 694,412 shares traded. Over the past week, the price has changed by -1.68%, over one month by -0.97%, over three months by -12.15% and over the past year by +23.65%.
Current recommended Stop Loss: 45.90 (which is 4.2% or 1.6 ATR below the current price).
Sonoco Products has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy SON.
- StrongBuy: 5
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 62.9 | 31.2% |
P/E Trailing = 7.5428
P/E Forward = 7.9491
P/S = 0.6427
P/B = 1.3996
P/EG = 0.2027
Revenue TTM = 7.46b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.55b USD
Long Term Debt = 3.48b USD (from longTermDebt, last quarter)
Short Term Debt = 968.8m USD (from shortTermDebt, last quarter)
Debt = 4.97b USD (from shortLongTermDebtTotal, last quarter) + Leases 259.2m
Net Debt = 4.80b USD (calculated: Debt 4.97b - CCE 168.6m)
Enterprise Value = 9.60b USD (4.80b + Debt 4.97b - CCE 168.6m)
Interest Coverage Ratio = 5.07 (Ebit TTM 1.03b / Interest Expense TTM 203.1m)
EV/FCF = 23.78x (Enterprise Value 9.60b / FCF TTM 403.7m)
FCF Yield = 4.21% (FCF TTM 403.7m / Enterprise Value 9.60b)
FCF Margin = 5.41% (FCF TTM 403.7m / Revenue TTM 7.46b)
Net Margin = 8.67% (Net Income TTM 646.8m / Revenue TTM 7.46b)
Gross Margin = 20.81% ((Revenue TTM 7.46b - Cost of Revenue TTM 5.91b) / Revenue TTM)
Gross Margin QoQ = 20.81% (prev 20.62%)
Tobins Q-Ratio = 0.87 (Enterprise Value 9.60b / Total Assets 11.0b)
Interest Expense / Debt = 4.08% (Interest Expense 203.1m / Debt 4.97b)
Taxrate = 21.09% (172.0m / 815.5m)
NOPAT = 812.5m (EBIT 1.03b * (1 - 21.09%))
Current Ratio = 0.99 (Total Current Assets 2.79b / Total Current Liabilities 2.80b)
Debt / Equity = 1.38 (Debt 4.97b / totalStockholderEquity, last quarter 3.60b)
Debt / EBITDA = 3.10 (Net Debt 4.80b / EBITDA 1.55b)
Debt / FCF = 11.90 (Net Debt 4.80b / FCF TTM 403.7m)
Total Stockholder Equity = 3.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 646.8m / Total Assets 11.0b)
RoE = 18.34% (Net Income TTM 646.8m / Total Stockholder Equity 3.53b)
RoCE = 14.69% (EBIT 1.03b / Capital Employed (Equity 3.53b + L.T.Debt 3.48b))
RoIC = 9.06% (NOPAT 812.5m / Invested Capital 8.97b)
WACC = 5.01% (E(4.80b)/V(9.77b) * Re(6.87%) + D(4.97b)/V(9.77b) * Rd(4.08%) * (1-Tc(0.21)))
Discount Rate = 6.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.77 | Cagr: 0.26%
[DCF] Terminal Value 77.97% ; FCFF base≈299.5m ; Y1≈343.4m ; Y5≈505.3m
[DCF] Fair Price = 28.33 (EV 7.60b - Net Debt 4.80b = Equity 2.80b / Shares 98.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 56.19 | EPS CAGR: 3.95% | SUE: 0.45 | # QB: 0
Revenue Correlation: 25.76 | Revenue CAGR: 3.86% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.94 | Chg30d=-0.56% | Revisions=+0% | Analysts=10
EPS current Year (2026-12-31): EPS=5.80 | Chg30d=-0.31% | Revisions=-25% | GrowthEPS=+1.6% | GrowthRev=-0.8%
EPS next Year (2027-12-31): EPS=6.32 | Chg30d=-0.43% | Revisions=-25% | GrowthEPS=+8.9% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: -29% (up=1, down=3)